Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate.

Delhi Pharmaceutical Sciences and Research University, 110017, New Delhi, India. Institute of Pharmacy, Nirma University, 382481, Ahmedabad, Gujarat, India. National Forensic Sciences University, Sector-9, Gandhinagar-382007, Gujarat, India. Delhi Pharmaceutical Sciences and Research University, 110017, New Delhi, India.

Molecular and cellular biochemistry. 2023;(10):2221-2240


COVID-19 is caused by severe acute respiratory syndrome coronavirus-2, SARS-CoV-2. COVID-19 has changed the world scenario and caused mortality around the globe. Patients who recovered from COVID-19 have shown neurological, psychological, renal, cardiovascular, pulmonary, and hematological complications. In some patients, complications lasted more than 6 months. However, significantly less attention has been given to post-COVID complications. Currently available drugs are used to tackle the complications, but new interventions must address the problem. Phytochemicals from natural sources have been evaluated in recent times to cure or alleviate COVID-19 symptoms. An edible plant, Solanum nigrum, could be therapeutic in treating COVID-19 as the AYUSH ministry of India prescribes it during the pandemic. S. nigrum demonstrates anti-inflammatory, immunomodulatory, and antiviral action to treat the SARS-CoV-2 infection and its post-complications. Different parts of the plant represent a reduction in proinflammatory cytokines and prevent multi-organ failure by protecting various organs (liver, kidney, heart, neuro, and lung). The review proposes the possible role of the plant S. nigrum in managing the symptoms of COVID-19 and its post-COVID complications based on in silico docking and pharmacological studies. Further systematic and experimental studies are required to validate our hypothesis.

Methodological quality

Publication Type : Review